Bios Equity Partners II, LP's Net Worth
$13.6 Million
Who is Bios Equity Partners II, LP?
Bios Equity Partners II, LP has an estimated net worth of $13.6 Million. This is based on reported shares across multiple companies, which include IN8BIO, INC., COGNITION THERAPEUTICS INC, Azitra Inc, and Lantern Pharma Inc..
SEC CIK
Bios Equity Partners II, LP's CIK is 0001813313
Past Insider Trading and Trends
2022 was Bios Equity Partners II, LP's most active year for acquiring shares with 37 total transactions. Bios Equity Partners II, LP's most active month to acquire stocks was the month of July. 2021 was Bios Equity Partners II, LP's most active year for disposing of shares, totalling 7 transactions. Bios Equity Partners II, LP's most active month to dispose stocks was the month of July. 2022 saw Bios Equity Partners II, LP paying a total of $5,885,106.28 for 3,678,253 shares, this is the most they've acquired in one year. In 2022 Bios Equity Partners II, LP cashed out on 356,445 shares for a total of $1,573,514.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
COGNITION THERAPEUTICS INC (CGTX) Snapshot price: $2.31
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 500.1K |
$1.05 | $525,099.75 | 500.1K |
Nov 8
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Jun 9
| |||
Form 4
| +0.61% | 16.06K |
$2.65 | $42,564.78 | 2.66M |
Nov 28
| |||
Form 4
| +2.76% | 71K |
$1.40 | $99,400.00 | 2.64M |
Nov 16
| |||
Form 4
| +140.01% | 1.5M |
$1.20 | $1,800,000.00 | 2.57M |
Nov 15
| |||
Form 4/A
|
∞
| 1.42M |
—
|
—
| 1.42M |
Oct 13
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lantern Pharma Inc. (LTRN) Snapshot price: $4.255
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -18.18% | -144.00K |
$4.70 | -$676,294.06 | 648.21K |
Feb 27 - Feb 29
| |||
Form 4
| +2.61% | 20.13K |
$3.67 | $1.93 | 792.21K |
Jan 17
| |||
Form 4
| -19.78% | -145.35K |
$3.44 | -$499,997.12 | 589.5K |
Nov 29
| |||
Form 4
| -18.85% | -350.00K |
$4.40 | -$1,540,000.00 | 1.51M |
Nov 8
| |||
Form 4
| +54.07% | 26.09K |
$3.12 | $0.14 | 74.35K |
Sep 2
| |||
Form 4
| +478.38% | 1.46M |
—
|
—
| 1.76M |
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Azitra Inc (AZTR) Snapshot price: $0.9601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +893.90% | 5.98M |
$5.00 |
—
| 6.65M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IN8BIO, INC. (INAB) Snapshot price: $1.23
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
| +1.55% | 75K |
$2.48 | $185,912.48 | 4.9M |
Dec 12
| |||
Form 4
| +0.52% | 25K |
$2.02 | $50,535.00 | 4.83M |
Sep 28
| |||
Form 4
| +1.08% | 51.21K |
$2.02 | $103,340.14 | 4.8M |
Aug 26 - Aug 29
| |||
Form 4
| +1.08% | 51.21K |
$2.02 | $103,340.14 | 4.8M |
Aug 26 - Aug 29
| |||
Form 4
| +1.06% | 50K |
$1.93 | $96,500.00 | 4.75M |
Aug 17
| |||
Form 4
| +69.31% | 1.77M |
$1.90 | $3,369,999.60 | 4.33M |
Aug 16
| |||
Form 4
|
∞
| 6.63M |
—
|
—
| 6.63M |
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||